The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice

Behavioural Brain Research

Volumn 237, Issue 1, 2013, Pages 41-48

  Tabaeizadeh, Mohammad ^a,b   Motiei Langroudi, Rouzbeh ^a,f   Mirbaha, Hilda ^a,c,e   Esmaeili, Behnaz ^d   Tahsili Fahadan, Pouya ^e   Javadi Paydar, Mehrak ^a,c   Ghaffarpour, Majid ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dependence; Mice; Morphine conditioned place preference; Orexin; SB 334867; TCS OX2 29

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; MORPHINE; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; RECEPTOR BLOCKING AGENT; TCS OX2 29; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, SURFACE; BENZOXAZOLES; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ISOQUINOLINES; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; PYRIDINES; RECEPTORS, CELL SURFACE; RECEPTORS, NEUROPEPTIDE; UREA;

EID: 84867087665     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.09.010     Document Type: Article

References (46)

1. Date Y., Ueta Y., Yamashita H., Yanaguchi H., Matsukura S., Kangawa K., et al. Orexins, orexinergic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:748-753.
2. De Lecea L., Kliduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins, hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:322-327.
3. Peyron C., Tighe D.K., van den Pol A.N., deLecea L., Heller H.C., Sutcliffe J.K., et al. Neurons containing hypocretins (orexins) project to multiple neuronal systems. Journal of Neuroscience 1998, 18:9996-10015.
4. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors; a family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
5. Ohno K., Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Frontiers in Neuroendocrinology 2008, 29:70-87.
6. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. Journal of Comparative Neurology 2001, 435(1):6-25.
7. Chemelli R.M., Willi J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 99:437-451.
8. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
9. Gorgescu D., Zachariou V., Barrot M., Mieda M., Willi J.T., Eisch A.J., et al. Involvement of lateral hypothalamic peptide orexin in morphine dependence and withdrawal. Journal of Neuroscience 2003, 23:3106-3111.
10. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
11. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., et al. Direct involvement of orexinergic systems in the activation of the mesolimbec dopamine pathway and related behaviors induced by morphine. Journal of Neuroscience 2006, 26:398-405.
12. Sharf R., Guarnieri D.J., Taylor J.R., Dileone R.J. Orexin mediates place preference, but not morphine-induced hyperactivity or sensitization. Brain Research 2010, 1317:24-32.
13. Nishino S. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders. Expert Opinion on Investigational Drugs 2007, 16:1785-1797.
14. Dugovic C., Shelton J.E., Aluisio L.E., Fraser I.C., Jiang X., Sutton S.W., et al. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. Journal of Pharmacology and Experimental Therapeutics 2009, 330:142-151.
15. Sharf R., Sarhan M., Dileone R.J. Role of orexin/hypocretin in dependence and addiction. Brain Research 2010, 1314:130-138.
16. Zhang G.C., Mao L.M., Liu X.Y., Wang J.Q. Long-lasting upregulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration. Journal of Neurochemistry 2007, 103:400-407.
17. Zhou Y., Cui C.L., Schlussman S.D., Choi J.C., Ho A., Han J.S., et al. Effect of cocaine place conditioning, chronic escalating-dose binge pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expression in lateral hypothalamus of Fischer and Sprauge-Dawley rats. Neuroscience 2008, 153:1225-1234.
18. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B. The orexin system regulates alcohol seeking in rats. British Journal of Pharmacology 2006, 148:752-759.
19. Sharf R., Sarhan M., Dileone R.J. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biological Psychiatry 2008, 64:175-183.
20. Smith R, See R, Aston-Jones G. The orexin-1 receptor antagonist SB-334867 blocks cue-induced reinstatement of cocaine seeking. Neuroscience meeting planner 2007. Online, program no 916.1.
21. Smith R.J., Tahsili-Fahadan P., Aston-Jones G. Orexin/hypocretin is necessary for context-driven cocaine seeking. Neuropharmacology 2010, 58:179-184.
22. Ishii Y., Blundell J.E., Halford J.C., Upton N., Porter R.A., Johns A., et al. Anorexia and weight loss in male rats 24h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behavioural Brain Research 2005, 157:331-341.
23. Moorman D.E., Aston-Jones G. Orexin 1 receptor antagonism decreases alcohol consumption and preference selectivity in high-ethanol-preferring Sprauge-Dawley rats. Alcohol 2009, 43:379-386.
24. Plaza-Zabala A., Flores A., Maldonado R., Berrendero F. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biological Psychiatry 2012, 71:214-223.
25. Zarrindast M.R., Mohajeri S. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of morphine withdrawal in dependent mice. European Journal of Pharmacology 2006, 15:90-98.
26. Sofuoglu M., Sato J., Takemori A.E. Maintenance of morphine dependence by naloxone in acutely dependent mice. Journal of Pharmacology and Experimental Therapeutics 1990, 254(3):841-846.
27. Tahsili-Fahadan P., Yahyavi-Firuz-Abadi N., Orandi A.H., Esmaeili B., Basseda Z., Dehpour A.R. Rewarding properties of sildenafil citrate in mice: role of the nitric oxide cycling-GMP pathway. Psychopharmacology (Berl) 2006, 185:201-207.
28. Zarrindast M.R., Heidari-Darvishani A., Rezayof A., Fathi-Azarbaijani F., Jafari-Sabet M., Hajizadeh-Moghadam A. Morphine-induced sensitization in mice: changes in locomotor activity by prior scheduled exposure to GABAA receptor agents. Behavioural Pharmacology 2007, 18(4):303-310.
29. Votava M., Krsiak M., Moravec V. Effects of alprazolam and fluoxetine on morphine sensitization in mice. Physiological Research 2002, 51:417-423.
30. Vekovischeva O.Y., Zamanillo D., Echenko O., Uusi-Oukari M., Honkanen A., Seeburg P.H., et al. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. Journal of Neuroscience 2001, 2001:4451-4459.
31. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., et al. Fos expression in orexin neurons varies with behavioral state. Journal of Neuroscience 2001, 21:1656-1662.
32. Fadel J., Deuth A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projection to the ventral tegmental area. Neuroscience 2002, 111:379-387.
33. Kane J.K., Parker S.L., Matta S.G., Fu Y., Sharp B.M., Li M.D. Nicotine upregulates expression of orexin and its receptors in rat brain. Endocrinology 2000, 141:3623-3629.
34. Morshedi M.M., Meredith G.E. Repeated amphetamine administration induces Fos in prefrontalcortical neurons the project to the lateral hypothalamus but not to the nucleus accumbens or basolateral amygdalia. Psychopharmacology 2008, 197:179-187.
35. Pasumarthi R., Reznikov L.R., Fadel J. Activation of orexin neurons by acute nicotine. European Journal of Pharmacology 2006, 535:172-176.
36. Smith R., See R., Aston-Jones G. Orexin/hypocretin signaling at OX1 receptor regulates cue-elicited cocaine seeking. European Journal of Neuroscience 2009, 30:493-503.
37. Martin G., Fabre V., Siggins G.R., De Lecea L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regulatory Peptides 2002, 104:111-117.
38. Tahsili-Fahadan P, Aston-Jones G. Role of the orexin system in reinstatement of the extinguished cocaine-seeking by contextual stimulus. Society of Neuroscience Abstract. Neuroscience meeting planner 2009. Online, program no. 253.16.
39. Shoblock J.R., Welty N., Aluisio L., Fraser I., Motley S.T., Morton K., et al. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 2011, 215:191-203.
40. 2 antagonists. Molecular Pharmacology 2009, 76:618-631.
41. Berrige K., Robinson T. What is the role of dopamine in reward: hedpnoc impact, reward learning, or incentive salience. Brain Research Reviews 1998, 28:309-369.
42. Jones S., Bonci A. Synaptic plasticity and drug addiction. Current Opinion in Pharmacology 2005, 5:20-25.
43. Kelley A.E. Memory and addiction: shared neuronal circuitry and molecular mechanisms. Neuron 2004, 44:161-179.
44. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
45. Schultz W. Neuronal coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioral ecology. Current Opinion in Neurobiology 2004, 14:139-147.
46. Wise R.A. Dopamine, learning and motivation. Nature Reviews Neuroscience 2004, 5:483-494.